Literature DB >> 14511361

Erythropoietin as an angiogenic factor.

D Ribatti1, A Vacca, A M Roccaro, E Crivellato, M Presta.   

Abstract

Erythropoietin (Epo) is produced by the fetal liver and adult kidney and is an essential stimulator of erythropoiesis. It has, however, been shown to modulate host cellular signal transduction pathway to perform many other functions. New sites of Epo production have been found, such as the female reproductive organs and central nervous system. This review summarizes the involvement of Epo in the regulation of angiogenesis in both normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511361     DOI: 10.1046/j.1365-2362.2003.01245.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  37 in total

Review 1.  Histological quantification of brain tissue inflammatory cell infiltration after focal cerebral infarction: a systematic review.

Authors:  Natanya S Russek; Matthew B Jensen
Journal:  Int J Neurosci       Date:  2013-09-18       Impact factor: 2.292

Review 2.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 3.  Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.

Authors:  Vijayeta Rangarajan; Sandra E Juul
Journal:  Pediatr Neurol       Date:  2014-06-24       Impact factor: 3.372

4.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

5.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

6.  Erythropoietin improves the survival of fat tissue after its transplantation in nude mice.

Authors:  Saher Hamed; Dana Egozi; Danny Kruchevsky; Luc Teot; Amos Gilhar; Yehuda Ullmann
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

Review 7.  The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

Authors:  Lois E Smith; Anna-Lena Hard; Ann Hellström
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

Review 8.  Erythropoietin (epoetin) as a protective factor for the brain.

Authors:  Samit Malhotra; Sheetal Nijhawan; Daniel M Rosenbaum
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

Review 9.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

Review 10.  Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator).

Authors:  Usha Panchapakesan; Siska Sumual; Carol Pollock
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.